Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders

References

• Johnson GD, Holborow EJ, Glynn LE. Antibody to smooth muscle in patients with liver disease. Lancet 1965; 2: 878–879
   PubMed Web of Science ®Google Scholar
• Toh BH. Smooth muscle autoantibodies and autoantigens. Clin Exp Immunol 1979; 38: 621–628
   PubMed Web of Science ®Google Scholar
• Selmi C, Muratori P, Podda M, Bianchi FB. Smooth muscle antibodies. Autoantibodies2nd ed., Y Shoenfeld, ME Gershwin, PL Meroni. Elsevier, Amsterdam 2007; 487–491
   Google Scholar
• Kurki P, Miettinen A, Salaspurd M, Virtanen I, Stenman S. Cytoskeleton antibodies in chronic active hepatitis, primary bilary cirrhosis, and alcoholic liver disease. Hepatology 1983; 3: 297–302
   PubMedGoogle Scholar
• Fusconi M, Cassani F, Zauli D, Lenzi M, Ballardini G, Volta U, Bianchi FB. Anti-actin antibodies: A new test for an old problem. J Immunol Methods 1990; 130: 1–8
   PubMed Web of Science ®Google Scholar
• Bottazzo GF, Florin Christensen A, Faifax A, Iwana G, Doniach D, Groeschel-Stevart U. Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Pathol 1976; 29: 403–410
   PubMed Web of Science ®Google Scholar
• Muratori P, Muratori L, Agostinelli D, Pappas G, Veronesi L, Granito A, Cassani F, Terlizzi P, Lenzi M, Bianchi FB. Smooth muscle antibodies and type 1 autoimmune hepatitis. Autoimmunity 2002; 35: 497–500
   PubMed Web of Science ®Google Scholar
• Cassani F, Fusconi M, Bianchi FB, Selleri L, Baffoni L, Lenzi M, Pisi E. Precipitine antibodies to rabbit thymus extractable antigens in chronic liver disease: Relationship with anti-actin antibodies. Clin Exp Immunol 1987; 68: 588–595
   PubMed Web of Science ®Google Scholar
• Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Concado BL, et al. Autoimmune hepatitis group report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929–938
   PubMed Web of Science ®Google Scholar
• Obermayer-Straub P, Strassburg CP, Manns MP. Autoimmune hepatitis. Hepatology 2000; 32: 181–197
   Google Scholar
• Cassani F, Cataleta M, Valentini P, Muratori P, Giostra A, Francescani R, Muratori L, Lenzi M, Bianchi G, Zauli D, Bianchi FB. Serum antibodies in chronic hepatitis C: Comparison with autoimmune hepatitis and impact in the disease profile. Hepatology 1997; 26: 561–566
   PubMed Web of Science ®Google Scholar
• Silvestrini RA, Benson EM. Whither smooth muscle antibodies in the third millennium?. J Clin Pathol 2001; 54: 677–678
   PubMed Web of Science ®Google Scholar
• Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology 1996; 24: 1968–1973
   Google Scholar
• Kurki P, Miettinen A, Linder E, Pikkarainen P, Vuoristo M, Salaspuro MP. Different types of smooth muscle antibodies in chronic active hepatitis and primary biliary cirrhosis: Their diagnostic and prognostic significance. Gut 1980; 21: 878–884
   PubMed Web of Science ®Google Scholar
• Bretherton L, Brown C, Pedersen JS, Toh BH, Clarke FM, Mackay IR, Gust ID. ELISA assay for IgG autoantibody to G-actin: Comparison of chronic active hepatitis and acute viral hepatitis. Clin Exp Immunol 1983; 51: 611–616
   PubMed Web of Science ®Google Scholar
• Dighiero G, Lymberi P, Monot C, Abuaf N. Sera with high levels of anti-smooth muscle and anti-mitochondrial antibodies frequently bind to cytoskeleton proteins. Clin Exp Immunol 1990; 82: 52–56
   PubMed Web of Science ®Google Scholar
• Leibovitch L, George J, Levi Y, Bakimer R, Shoenfeld Y. Anti-actin antibodies in sera from patients with autoimmune liver diseases and patients with carcinomas by ELISA. Immunol Lett 1995; 48: 129–132
   PubMedGoogle Scholar
• Zamanou A, Tsirogianni A, Terzoglou C, Balafas A, Economidou I, Lymbery P. Anti-smooth muscle antibodies (ASMAs) and anti-cytoskeleton antibodies (ACTAs) in liver disease: A comparison of classical indirect immunofluorescence with ELISA. J Clin Lab Anal 2002; 16: 194–201
   PubMedGoogle Scholar
• Zamanou A, Samiotaki M, Panayotoo G, Margaritis L, Lymberi P. Fine specificity and subclasses of IgG anti-actin autoantibodies differ in healthy and disease. J Autoimmun 2003; 20: 333–344
   PubMedGoogle Scholar
• Granito A, Muratori L, Muratori P, Pappas G, Guidi G, Guidi M, Cassani F, Volta U, Ferri A, Lenzi M, Bianchi FB. Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. J Clin Pathol 2006; 59: 280–284
   PubMed Web of Science ®Google Scholar
• Chretien-Leprince P, Ballot E, Andre C, Olsson ND, Fabien N, Escande A, Oksman F, Bubuquoi S, Jego S, Goetz J, Chevalier A, Sanmarco M, Humbel RL, Johanet C. Diagnostic value of anti-F-actin antibodies in a French multicenter study. Ann NY Acad Sci 2005; 1050: 266–273
   PubMed Web of Science ®Google Scholar
• Czaja AJ. Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology 1998; 28: 360–365
   PubMed Web of Science ®Google Scholar
• Lohse AW, Gerken G, Mohr H, Lohr HF, Treichel U, Dienes HP, Mayerzum Buschenfelde KH. Relation between autoimmune liver diseases and viral hepatitis: Clinical and serological characteristics in 859 patients. Z Gastroenterol 1995; 33: 527–533
   PubMedGoogle Scholar
• Frenzel C, Herkel J, Lüth S, Galle PR, Schramm C, Lohse AW. Evaluation of F-actin ELISA for the diagnosis of autoimmune hepatitis. Am J Gastroenterol 2006; 101: 2731–2736
   PubMed Web of Science ®Google Scholar
• Concado ELR, Abrantes-Lemos CP, Vilas-boas LS, Novo NF, Carrilho FJ, Laudanna AA. Thermolabile and calcium-dependent serum factor interferes with polymerized actin, and impairs anti-actin antibody detection. J Autoimmun 2001; 17: 223–228
   PubMedGoogle Scholar